Breast Imaging: Page 73

DBT helps detect, characterize dense tissue masses
By Kate Madden Yee
CHICAGO - Digital breast tomosynthesis (DBT) shows promise in detecting and characterizing masses, particularly in women with dense breast tissue, researchers said in a Tuesday session at the RSNA meeting. But the technology still has some important areas for growth.
November 29, 2011
3T breast MRI bests 1.5T in detecting additional cancer
By Kate Madden Yee
Thursday, December 1 | 9:20 a.m.-9:30 a.m. | MSVB51-05 | Room E451BThree-tesla breast MRI appears slightly better than 1.5-tesla in detecting suspicious lesions in patients with newly diagnosed breast cancer, according to researchers at Yale University.
November 14, 2011
Decision-support guidelines prove effective for breast MRI guidelines
By Cynthia E. Keen
Wednesday, November 30 | 11:30 a.m.-11:40 a.m. | SSK09-07 | Room S405ABHow has the use of clinical decision-support software affected breast MRI use? In this scientific paper presentation, Dr. Vartan Vartanians, a research fellow in radiology at Massachusetts General Hospital, will discuss an analysis of 10 years of ordering patterns.
November 10, 2011
FDA accepts U-Systems' PMA for ABUS
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has accepted ultrasound developer U-Systems' premarket approval (PMA) application for use of the firm's somo.v automated breast ultrasound (ABUS) system for breast cancer screening.
November 9, 2011
GE starts PMA process for digital breast tomo
By AuntMinnie.com staff writers
GE Healthcare has submitted to the U.S. Food and Drug Administration the first module of its premarket approval (PMA) application for a digital breast tomosynthesis system.
November 9, 2011
Road to RSNA 2011: Women's Imaging Preview
By Kate Madden Yee
For the RSNA 2011 conference, attendees will encounter sessions and posters that examine current issues in breast imaging, such as imaging of reconstructed breasts and management of high-risk lesions. Breast ultrasound also will be a highlight this year.
November 8, 2011
Road to RSNA 2011: Women's Imaging Preview
Screening mammography utilization rises among Medicare beneficiaries
By Kate Madden Yee
Friday, December 2 | 11:20 a.m.-11:30 a.m. | SST01-06 | Room E450BThe utilization rate of screening mammography per 1,000 women in the Medicare population is rising, although the rate of diagnostic mammography is falling, according to researchers at Thomas Jefferson University Hospital in Philadelphia.
November 8, 2011
3T breast MRI bests 1.5T in detecting additional cancer
By Kate Madden Yee
Thursday, December 1 | 9:20 a.m.-9:30 a.m. | MSVB51-05 | Room E451BThree-tesla breast MRI appears slightly better than 1.5-tesla in detecting suspicious lesions in patients with newly diagnosed breast cancer, according to researchers at Yale University.
November 8, 2011
DBT more accurate than FFDM in interpreting mammographic signs
By Kate Madden Yee
Wednesday, November 30 | 11:50 a.m.-12:00 p.m. | SSK01-09 | Arie Crown TheaterIn this Wednesday session, researchers will present their results on how digital breast tomosynthesis (DBT) better visualizes some mammographic lesions with nonspecific features on full-field digital mammography (FFDM).
November 8, 2011
DBT plus FFDM increases cancer detection rates for high-risk women
By Kate Madden Yee
Tuesday, November 29 | 10:30 a.m.-10:40 a.m. | MSVB31-10 | Arie Crown TheaterUsing full-field digital mammography (FFDM) with digital breast tomosynthesis (DBT) increases the cancer detection rate in women with dense breasts, according to researchers at Massachusetts General Hospital.
November 8, 2011
Adding DBT to screening mammography decreases recall rates
By Kate Madden Yee
Tuesday, November 29 | 10:10 a.m.-10:20 a.m. | MSVB31-08 | Arie Crown TheaterUsing digital breast tomosynthesis (DBT) in combination with full-field digital mammography decreases recall rates during baseline screening mammography of women between the ages of 39 and 56, according to researchers at the University of Pittsburgh.
November 8, 2011
Interpretation time for DBT acceptable for breast cancer screening
By Kate Madden Yee
Tuesday, November 29 | 9:50 a.m.-10:00 a.m. | MSVB31-07 | Arie Crown TheaterIn this Tuesday morning talk, Oslo University Hospital researchers will discuss their study showing that interpretation time for digital breast tomosynthesis (DBT) is longer than with full-field digital mammography, but it's still acceptable for high-volume batch mode screening.
November 8, 2011
Previous Page
Page 73 of 89
Next Page